Microglia Mediated Neuroinflammation: Focus on PI3K Modulation

Antonia Cianciulli1, Chiara Porro2, Rosa Calvello1

  • 1Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, 70125 Bari, Italy.

Biomolecules
|January 18, 2020
PubMed

Insights

Microglia-driven neuroinflammation in the central nervous system can cause damage. This review explores how phosphoinositide 3-kinases (PI3Ks) impact this process and offers potential therapeutic strategies for neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Immunology
  • Molecular Biology

Background:

  • Microglia are key immune cells in the central nervous system, responding to threats but potentially causing damage if inflammation is prolonged.
  • Neurodegenerative diseases are often associated with chronic inflammation and the production of neurotoxic factors by microglia.
  • Phosphoinositide 3-kinases (PI3Ks) are crucial intracellular enzymes involved in various cellular activities, including signal transduction.

Purpose of the Study:

  • To review recent findings on the role of the PI3K signaling pathway in modulating microglia-mediated neuroinflammation.
  • To discuss the implications of PI3K activity in the context of neurodegenerative diseases.
  • To explore the potential of targeting PI3K as a therapeutic strategy for neurodegenerative conditions.

Main Methods:

  • Literature review of recent studies on PI3K signaling and neuroinflammation.
  • Analysis of the role of PI3K in microglia activation and function.
  • Discussion of therapeutic interventions targeting PI3K in neurodegeneration models.

Main Results:

  • PI3K signaling pathways are implicated in the regulation of microglia's inflammatory responses.
  • Dysregulation of PI3K activity can contribute to neurotoxic processes associated with neurodegeneration.
  • Specific PI3K isoforms and their downstream targets influence the balance between protective and detrimental microglial functions.

Conclusions:

  • The PI3K pathway plays a critical role in the neuroinflammatory responses of microglia.
  • Modulating PI3K activity presents a promising avenue for developing novel therapeutic strategies against neurodegenerative diseases.
  • Further research into PI3K signaling in microglia could lead to targeted treatments for conditions like Alzheimer's and Parkinson's disease.